Skip to Content

niraparib 100 mg (Zejula 100 mg)

Generic Name: niraparib

Pill with imprint niraparib 100 mg is Purple / White, Capsule-shape and has been identified as Zejula 100 mg. It is supplied by Tesaro Inc..

Zejula is used in the treatment of ovarian cancer; fallopian tube cancer; peritoneal cancer and belongs to the drug class PARP inhibitors. Zejula 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for niraparib 100 mg

Zejula 100 mg niraparib 100 mg

Zejula

Generic Name
niraparib
Imprint
niraparib 100 mg
Strength
100 mg
Color
Purple / White
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
PARP inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Tesaro Inc.
National Drug Code (NDC)
69656-0103
Inactive Ingredients
magnesium stearate, lactose monohydrate, titanium dioxide, gelatin hydrolysate (porcine skin, mw 3000), FD&C Blue No. 1, FD&C Red No. 3, FD&C Yellow No. 5

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.